Synonym: 11β,17α,21-Trihydroxypregn-4-ene-3,20-dione; 17-Hydroxycorticosterone; 4-Pregnene-11β,17α,21-triol-3,20-dione; Cortisol; Kendall’s compound F; Reichstein’s substance M
CAS Number: 50-23-7
Empirical Formula (Hill Notation): C21H30O5
Molecular Weight: 362.46
EC Number: 200-020-1
MDL Number: MFCD00011654
Linear Formula: C21H30O5
Product Type: Chemical
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: H3160-25G
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: H3160-10G
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: H3160-5G
| agency |
meets USP testing specifications |
| |
USP/NF |
| application(s) |
pharmaceutical (small molecule) |
| assay |
97.0-102.0% dry basis |
| biological source |
plant (wild yam) |
| form |
powder |
| InChI |
1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 |
| InChI key |
JYGXADMDTFJGBT-VWUMJDOOSA-N |
| mp |
211-214 °C (lit.) |
| potency |
0.004-0.005 μg/mL |
| Quality Level |
300  |
| SMILES string |
[H][C@@]12CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]4(C)[C@@]2([H])CC[C@]4(O)C(=O)CO |
| solubility |
water: soluble 0.28 g/L at 25 °C |
| Application: |
- Exploring Microemulsion Systems for the Incorporation of Glucocorticoids into Bacterial Cellulose: This research presents a novel method for embedding hydrocortisone into bacterial cellulose using microemulsion systems, highlighting its potential for creating anti-inflammatory wound dressings, a significant advancement in pharmaceutical design and material science (Zahel et al., 2024
 ).
- Research progress in the treatment of chronic fatigue syndrome through interventions targeting the hypothalamus-pituitary-adrenal axis: This review discusses the role of hydrocortisone in treating chronic fatigue syndrome by modulating the hypothalamus-pituitary-adrenal axis, providing a comprehensive overview of its therapeutic applications in endocrinology (Zhang and Wang, 2024
 ).
|
| Biochem/physiol Actions: |
Primary glucocorticoid secreted by the adrenal cortex. |
| Biochem/physiol Actions: |
Primary glucocorticoid secreted by the adrenal cortex. It has three times the anti-inflammatory potency of corticosterone but much lower Na2+ retention potency. |
| Packaging: |
5, 10, 25 g in poly bottle |
| Physical form: |
powder-RT; stock-frozen in working aliquots, avoid repeated freeze/thaw |
| Purity |
97.0-102.0% dry basis |
| mp |
211-214 °C (lit.) |
| UNSPSC |
51111800 |